LGND
LGND
NASDAQ · Pharmaceuticals

Ligand Pharmaceuticals

$313.58
+7.38 (+2.41%)
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Buy 16 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target -89.9% upside
Low Target $18.80
Average Target $31.56
High Target $35.41
Current Price $313.58
Current
$313.58
Target
$31.56
$18.80 $31.56 avg $35.41
Scenario Analysis
Bear Case
$18.80
-94.0%
Low target
Base Case
$31.56
-89.9%
Avg target
Bull Case
$35.41
+-88.7%
High target
Risk/Reward
0.9x
Unfavorable
Price in Context
52-Week High
$326.63
-4.0% from high
52-Week Low
$175.89
+78.3% from low
50-Day SMA
$299.49
+4.7% vs SMA
200-Day SMA
$255.99
+22.5% vs SMA
RSI (14)
53.9
Neutral
Target vs 52W High
$31.56
-90.3% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 37 86% $1,330.33 -6.5%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 70% $299.55 +6.2%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 34 38% $33.90 +15.9%
BMY
Bristol-Myers Squibb Co
Hold 34 41% $174.50 +180.5%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -47.3%
ZTS
Zoetis Inc
Hold 22 41% $209.87 +156.1%